Y. Gan et al. / Tetrahedron: Asymmetry 20 (2009) 723–725
725
removed in vacuo and purification by gradient column chromatography
eluting with diethyl ether/petroleum ether (30–40 °C) and triethylamine (2%)
afforded 6a–e.
and the free amine derivatives of 8c have been used to access the
C-13 side chain of TaxolÒ.19
General cycloadduct degradation procedure: To a 0.05 M solution 6a–e of in THF/
water (3:1) was added p-TSA (1 mol %). The reaction was monitored by TLC
analysis and, when the cycloadduct was no longer observed, the solvents were
removed in vacuo. The crude hydrolysis product was dissolved in THF/water
(3:1) to make a 0.05 M solution, cooled to 0 °C and a hydrogen peroxide
solution (30% w/w) (6 equiv) was added, followed by solid lithium hydroxide
monohydrate (2 equiv). The solution was warmed to room temperature over
2 h and left to stir until the hydrolysis product was no longer present by TLC
analysis. The reaction mixture was recooled to 0 °C and quenched by addition
of a 1.5 M aqueous sodium thiosulfate solution (6.6 equiv). The solution was
adjusted to pH 8 with 4 M aqueous hydrochloric acid and the solvents were
removed in vacuo. Purification by gradient column chromatography eluting
with chloroform/ethanol, gave 1 and 8a–e.
3. Conclusion
In conclusion, we have developed a highly diastereocontrolled
synthesis of enantiopure b-amino-a-hydroxy acids, via the cyc-
loadditions of imines with the carbonyl ylide derived from chiral
precursor 1. After cleavage, the chiral auxiliary 1 was recovered
in excellent yield, with the b-amino-a-hydroxy acids 8a–e isolated
in reasonable to good yields. Optimisation studies of the carbonyl
ylide generation/cycloaddition step demonstrated the dramatic
effect of the use of nitromethane as a solvent.
Compound 6a: mp 124–125 °C; m/z C27H26N2O4 requires 442.1893, found
442.1899;
dH (400 MHz, CDCl3) 7.41–6.65 (14H, m, ArH), 4.97 (1H, dd, J 5.0, J0 9.5 Hz, 10
H), 4.72 (1H, d, J 13.0 Hz, NCHHPh), 4.60 (1H, d, J 12.5 Hz, 7
(1H, s, 3-H), 4.32 (1H, d, J 12.5 Hz, 7
-H or 7b-H), 4.08 (1H, dd, J 5.0, J0 12.0 Hz,
-H or 9b-H), 3.73, (3H, s, CH3), 3.68 (1H, d, J 13.0 Hz, NCHHPh), 3.59 (1H, s,
4H) and 3.54 (1H, dd, J 10.0, J0 12.0 Hz, 9
-H or 9b-H); dC (101 MHz, CDCl3)
m
max (thin film) 1728, 1609, 1511, 1454, 1421, 1336 and 1244 cmꢀ1
;
a-
a
-H or 7b-H), 4.48
Acknowledgements
a
9a
S.C.R thanks GlaxoSmithKline and the University of Reading
(R.E.T.F) for financial support.
a
171.5, 158.8, 137.2, 135.7, 132.4, 128.8, 128.7, 128.4, 128.0, 127.2, 127.0, 113.2,
101.0, 86.0, 73.1, 69.5, 65.6, 58.5, 55.2 and 55.1; ½a D20
¼ ꢀ204:3 (c 0.5 CHCl3);
ꢂ
Anal. Calcd for C27H26N2O4: C, 73.29; H, 5.92; N, 6.33. Found: C, 73.14; H, 5.99;
N, 6.35. Compound 6c: m/z C26H24N2O3 requires 412.1787, found 412.1787;
mmax (thin film) 1728, 1496, 1457, 1423, 1336 and 1071 cmꢀ1; dH (250 MHz,
References
CDCl3) 7.44–7.05 (15H, m, ArH), 4.97 (1H, dd, J 4.5, J0 9.5 Hz, 10
a
-H), 4.74 (1H,
-H or 7b-H), 4.50 (1H, s, 3-H),
-H or 7b-H), 4.06 (1H, dd, J 4.5, J0 12.0 Hz, 9
-H or 9b-
H), 3.68 (1H, d, J 13.0 Hz, NCHHPh), 3.62 (1H, s, 4H) and 3.53 (1H, dd, J 9.5, J0
12.0 Hz, 9 -H or 9b-H); dC (62.8 MHz, CDCl3) 171.9, 140.6, 137.5, 136.1, 129.4,
129.2, 129.1, 128.9, 128.5, 128.4, 128.3, 127.7, 127.0, 101.5, 86.4, 73.5, 69.9,
66.6, 58.9 and 55.7; [
D = ꢀ175.2 (c 0.4 CHCl3). Compound 8a: mp 204–207 °C;
1. Katsuki, T.; Sharpless, K. B. J. Am. Chem. Soc. 1980, 102, 5974.
2. Denis, J. N.; Correa, A.; Greene, A. E. J. Org. Chem. 1990, 55, 1957.
3. Torssell, S.; Kienle, M.; Somfai, P. Angew. Chem., Int. Ed. 2005, 44, 3096.
4. Denis, J. N.; Correa, A.; Greene, A. E. J. Org. Chem. 1991, 56, 6939.
5. Umezawa, H.; Aoyagi, T.; Suda, H.; Hamada, M.; Takeuchi, T. J. Antibiot. 1976,
29, 97.
6. Rich, D. H. J. Med. Chem. 1985, 28, 263.
7. Moon, S. S.; Chen, J. L.; Moore, R. E.; Patterson, G. M. L. J. Org. Chem. 1992, 57,
1097.
8. Juaristi, E. Enantioselective Synthesis of b-Amino Acids; John Wiley & Sons: New
York, 1997.
9. Nicolaou, K. C.; Dai, W. M.; Guy, R. K. Angew. Chem., Int. Ed. 1994, 33, 15.
10. Crown, J.; O’Leary, M. Lancet 2000, 355, 1176.
11. Angell, R.; Fengler-Veith, M.; Finch, H.; Harwood, L. M.; Tucker, T. T.
Tetrahedron Lett. 1997, 38, 4517.
12. Drew, M. G. B.; Fengler-Veith, M.; Harwood, L. M.; Jahans, A. W. Tetrahedron
Lett. 1997, 38, 4521.
d, J 13.0 Hz, NCHHPh), 4.62 (1H, d, J 12.5 Hz, 7
4.32 (1H, d, J 12.5 Hz, 7
a
a
a
a
a
]
m/z C17H19NO4 requires 302.1392, found 302.1387; mmax (thin film) 3389, 2918,
1602, 1507, 1247, 1177, 1113 and 1026 cmꢀ1; dH (400 MHz, D2O); 7.56–7.10
(9H, m, ArH), 4.25 (1H, d, J 6.5 Hz N–CH), 4.14 (1H, d, J 6.5 Hz, O–CH), 3.95 (1H,
d, J 13.5 Hz, NCHHPh), 3.94 (3H, s, OCH3) and 3.84 (1H, d, J 13.5 Hz, NCHHPh);
dC (101 MHz, D20); 180.4, 161.7, 132.5, 131.9, 131.8, 131.6, 131.4, 130.9, 116.9,
77.1, 66.1, 58.1 and 51.6; ½a D20
¼ ꢀ31:7 (c 1.0 MeOH). Compound 8c: mp 146–
ꢂ
149 °C; m/z C16H17NO3 requires 272.1286, found 272.1276; mmax (thin film)
3399, 3058, 2845, 1600, 1454, 1369, 1124 and 697 cmꢀ1; dH (400 MHz, D2O/
MeOD); 7.44–7.10 (10H, m, ArH), 4.14 (1H, d, J 5.5 Hz N–CH), 4.10 (1H, d, J
5.5 Hz, O–CH), 3.92 (1H, d, J 13.5 Hz, NCHHPh) and 3.85 (1H, d, J 13.5 Hz,
NCHHPh); dC (101 MHz, D2O/MeOD); 178.9, 135.1, 134.2, 132.3, 132.1, 131.9,
13. Sato, M.; Kanuma, N.; Kato, T. Chem. Pharm. Bull. 1982, 30, 1315.
14. Green, G. M.; Peet, N. P.; Metz, W. A. J. Org. Chem. 2001, 66, 2509.
15. Regitz, M. Angew. Chem., Int. Ed. Engl. 1967, 6, 733.
16. All novel compounds isolated gave spectroscopic data in accordance with their
assigned structures. General experimental and selected data for key products
are given below.
131.4, 130.7, 127.9, 75.4, 66.3 and 51.6; ½a D20
¼ ꢀ51:9 (c 0.95 MeOH).
ꢂ
17. Crystal data for 6a: C27H26N2O4 M = 442.5, orthorhombic, P212121, a = 9.5588(2),
b = 10.2099(3), c = 22.1559(4) Å, V = 2162.29(9) Å3, Z = 4, D = 1.359 g cmꢀ3
,
F(000) = 936. 3712 Independent reflections were collected on an Oxford
Gemini S Ultra Image Plate System. The structures were solved by direct
methods and refined on F2 using SHELX97. Final R = 0.0417, weighted R = 0.1327.
CCDC 717010 contains the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge Crystallographic
General cycloaddition procedure: To Rh2(OAc)4 (2 mol %) and 3 Å molecular
sieves in nitromethane (1 mL) under an inert atmosphere, was added a 0.81 M
solution of 5a–e in nitromethane followed by the dropwise addition of a
0.27 M solution of 2 in nitromethane. The reaction was left to stir until TLC
analysis showed no evidence of the ylide precursor. The molecular sieves were
removed by filtration and washed with DCM (3 ꢁ 5 mL), the solvent was
18. Evans, D. A.; Britton, T. C.; Ellman, J. A. Tetrahedron Lett. 1987, 28, 6141.
19. Borah, J. C.; Boruwa, J.; Barua, N. C. Curr. Org. Chem. 2007, 4, 175.